Other · developed by Xenon Pharmaceuticals
XPF-005 is a topical gel applied to the face.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02656043 | Phase 1/2 | Acne Vulgaris | Completed | XENE |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acne Vulgaris
Updated Nov 1, 2026. Something wrong or missing? Report it on the XENE page.
See XENE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
XENE catalysts and pipeline →